morning, Thanks, Ron. everyone. Good
our first fiscal Let’s quarter slide results. financial and review to nine turn XXXX
mid-single versus Akorn. today’s of were America non-GAAP digits the closest and $XXX.X flat As acquisition but a prior declined increased our our revenues down presentation million X.X% effects QX release. Akorn. information the GAAP that foreign revenue earnings reminder, North year, in the reconciled approximately of is the to excluding and measure year information certain versus in X.X% includes excluding currency prior of
experienced when notably vaccination we higher in As unique the consumers faced QX rates. increased year most as dramatically a in reminder, with travel habits, prior sales the shifted comparison
segment International Ron up Hydralyte XX% discussed over FX, of Our by million excluding revenues QX the earlier. brand in led strength, were $XX.X
EBITDA the and declined EPS QX unusual As slightly with in EBITDA expected, both but long-term consistent from in the remained margin expectations year, prior our mid-XXs.
turn Let’s consolidated details XX for to slide around more results.
year. QX XXXX We our experienced cold categories increased including Remedies brands highlighted, just fiscal I Chloraseptic, Little robust our and demand and X.X% experienced across all the Luden’s consumer growth. versus As prior cough several revenues where
This in the gross continuing points online in higher We purchasing. trend declined as the and long-term year’s also basis gross channel, product of to XXX continue company the to Total experience double-digit of last attributable timing of expected growth XX.X% margin e-commerce cost mix. quarter was margin. increases versus year-over-year the and
fiscal approximate margin Advertising continue across QX anticipate of for XX.X% the inflationary dollar in and to and XXXX, continue We fiscal institute XX% an to first and for pricing marketing actions came headwinds. amount of at gross both to we our portfolio offset quarter. the
of timing anticipate of expenses we of we higher just G&A anticipated year G&A slightly For dollars over anticipate year full XX% sales. still at fiscal but A&M sales. to rate still in than of prior sales QX, to the X.X% due an were around of expenses, X% approximate certain XXXX,
year, EPS from down Finally, of the in $X.X, previously $X.XX to diluted prior factors the discussed. compared
prior was rate to generated of XXXX full $X.XX rate of benefit. certain approximately tax tax XX% QX anticipate We year a the Our tax discrete due below a items, of EPS XX%. periods timing still fiscal which
the cash discuss and XX slide the In free to year capital. prior in timing million $XX.X turn working down let’s versus we flow, of flow. Now to generated due QX, cash
to higher X.X We fiscal program versus XXX,XXX of was maintain approximately the and expense maintained in XXth, back At our it share maintaining Ron. our $X.X and net defined anticipate repurchasing ratio we times leverage May, still I authorized being debt anticipate will X.X that, industry-leading repurchasing quarter, for continue free slightly the times. billion prior are and year to by year. the our covenant $XX leverage in $XX turn million shares. flow utilized cash We of Lastly, million year-end June outlook we approximately approximately the With interest below
